| Name | 1-(4-methylphenyl)sulfonyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolo[2,3-b]pyridine |
|---|---|
| Synonyms |
4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tosyl-1H-pyrrolo[2,3-b]pyridine
1-[(4-methylphenyl)sulphonyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(toluene-4-suIfonyl)-1H-pyrrolo[2,3-b]pyridine 1-Tosyl-1H-Pyrrolo[2,3-B]pyridine-4-boronic acid pinacol ester 1-[(4-Methylphenyl)sulfonyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine |
| Molecular Formula | C20H23BN2O4S |
|---|---|
| Molecular Weight | 398.28400 |
| Exact Mass | 398.14700 |
| PSA | 78.80000 |
| LogP | 3.96170 |
|
~97%
916176-50-6 |
| Literature: VERTEX PHARMACEUTICALS INCORPORATED Patent: WO2006/127587 A1, 2006 ; Location in patent: Page/Page column 86 ; WO 2006/127587 A1 |
|
~%
916176-50-6 |
| Literature: US2011/306613 A1, ; |
|
~%
916176-50-6 |
| Literature: US2011/306613 A1, ; |
|
~%
916176-50-6 |
| Literature: US2011/306613 A1, ; |
| Precursor 5 | |
|---|---|
| DownStream 0 | |